Logo

Acrongenomics Begins Private Placement Financing

Nov 22, 2004

NEW YORK, Nov. 22 (GenomeWeb News) - Acrongenomics, formerly Cellway Ventures, said last week that it is beginning a private placement financing for 400,000 of its shares at $2.50 per share.

 

The company said that a finders fee of 10 percent in stock will be paid upon the closing of the financing round.

 

Acrongenomics said it plans to use the proceeds of the financing to support ongoing validation studies of its first product, the NeoEpCam cancer detection kit.

 

Breaking News
The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.